FORA
Forian Inc
NASDAQ: FORA · HEALTHCARE · HEALTH INFORMATION SERVICES
$2.16
+0.23% today
Updated 2026-04-30
Market cap
$67.33M
P/E ratio
—
P/S ratio
2.23x
EPS (TTM)
$-0.09
Dividend yield
—
52W range
$2 – $3
Volume
0.0M
Forian Inc (FORA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-1017.2%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.3%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-2.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-01 | $-0.06 | -731.2% | $2.07 | $2.10 | +1.4% |
| 2025-12-31 | $-0.00 | -132.0% | $2.11 | $2.12 | +0.5% |
| 2025-11-06 | $0.02 | +50.4% | $2.21 | $2.15 | -2.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $0.01 | $-0.06 | -731.2% | — | — |
| 2025-12-31 | $0.01 | $-0.00 | -132.0% | $7.96M | +37.0% |
| 2025-09-30 | $0.01 | $0.02 | +50.4% | $7.76M | +65.6% |
| 2025-06-30 | $0.01 | $0.01 | +0.0% | $7.48M | +56.5% |
| 2025-03-31 | $-0.02 | $0.01 | +132.0% | $7.06M | +44.7% |
| 2024-12-31 | $0.02 | $0.08 | +296.5% | $5.81M | +8.3% |
| 2024-09-30 | $-0.03 | $0.02 | +179.0% | $4.69M | -12.4% |
| 2024-06-30 | $-0.02 | $-0.08 | -300.0% | $4.78M | — |
| 2024-03-31 | $-0.02 | $-0.04 | -100.0% | $4.88M | — |
| 2023-12-31 | $-0.03 | $0.04 | +233.3% | $5.37M | — |
| 2023-09-30 | $-0.03 | $0.13 | +533.3% | $5.35M | — |
Frequently asked questions
Has Forian Inc beaten earnings estimates?
Forian Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports.
How does FORA stock react to earnings?
FORA stock has moved an average of -0.3% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.